Related Experiment Video
Updated: Feb 1, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Identification of Key Potential Targets and Pathway for Arsenic Trioxide by Systemic Bioinformatics Analysis in
Yanan Pang1, Zhiyong Liu1, Shanrong Liu2
1Department of Laboratory Diagnostics, Changhai Hospital, Second Military Medical University, Shanghai, 200433, China.
Abstract:
Arsenic trioxide is an approved chemotheraputic agent for the treatment of acute promyelocytic leukemia (APL). Recently, numerous studies suggested that arsenic trioxide acts as anti-cancer roles in various human malignancies. However, the molecular mechanisms are not fully elucidated. In this study, we explored the critical targets of arsenic trioxide and their interaction network systematically by searching the publicly available published database like DrugBank (DB) and STRING. Seven direct protein targets (DPTs) and 111 DPT-associated genes were identified. The enrichment analysis of arsenic trioxide associated genes/proteins revealed 10 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Among these pathways, phosphatidylinositol-4,5-bisphosphate-3-kinase -Akt (PI3K-Akt) single pathway and pancreatic cancer pathway are highly correlated with arsenic trioxide and have 5 overlapped targets. Then we investigated the gene alternation of selected critical genes in pancreatic cancer studies using cBio portal. These results indicated that arsenic trioxide could act anti-tumor function through PI3K-Akt single pathway and identified critical genes might be therapeutic targets for pancreatic cancer.
Insights
Arsenic trioxide shows anti-cancer effects beyond leukemia. This study identifies key molecular targets and pathways, including the PI3K-Akt pathway, suggesting new therapeutic strategies for pancreatic cancer.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Arsenic trioxide is approved for acute promyelocytic leukemia (APL).
- Emerging evidence suggests broader anti-cancer roles in various malignancies.
- The precise molecular mechanisms underlying its anti-cancer activity remain incompletely understood.
Purpose of the Study:
- To systematically explore the direct protein targets (DPTs) of arsenic trioxide.
- To elucidate the interaction network of DPTs and associated genes.
- To identify potential therapeutic targets for arsenic trioxide in cancer treatment.
Main Methods:
- Utilized public databases like DrugBank (DB) and STRING for target identification.
- Performed systematic network analysis of identified targets and associated genes.
- Conducted enrichment analysis using Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways.
- Investigated gene alternations in pancreatic cancer using the cBio portal.
Main Results:
- Identified seven direct protein targets (DPTs) and 111 DPT-associated genes.
- Revealed 10 KEGG pathways associated with arsenic trioxide's action.
- Highlighted the phosphatidylinositol-4,5-bisphosphate-3-kinase -Akt (PI3K-Akt) pathway and pancreatic cancer pathway as highly correlated, sharing five targets.
- Observed significant gene alternations in pancreatic cancer for selected critical genes.
Conclusions:
- Arsenic trioxide exhibits anti-tumor functions potentially mediated through the PI3K-Akt signaling pathway.
- The identified critical genes represent potential therapeutic targets for pancreatic cancer treatment.
- Further research into arsenic trioxide's molecular mechanisms could lead to novel cancer therapies.
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Key Techniques in Microbiology
Key Elements for Plant Nutrition
Cancer Survival Analysis
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...

